Patents Assigned to Biopeptides LLC
  • Peptides for diagnosing lyme disease
    Patent number: 10006912
    Abstract: The present invention relates, e.g., to a composition comprising peptides represented by SEQ ID NO:1, or active variants thereof, wherein the peptides or active variants can bind specifically to an antibody induced by a causative agent of Lyme disease (a pathogenic Borrelia), e.g. in a sample from a subject having Lyme disease. Compositions of the invention may comprise multiple peptides, from multiple proteins. Diagnostic kits comprising the peptides are described, as are diagnostic assays using the peptides.
    Type: Grant
    Filed: December 8, 2014
    Date of Patent: June 26, 2018
    Assignee: Biopeptides LLC
    Inventors: Raymond J. Dattwyler, Paul M. Arnaboldi